Literature DB >> 18428347

Genotyping of apolipoprotein E: comparative evaluation of different protocols.

Martin Ingelsson1, Youngah Shin, Michael C Irizarry, Bradley T Hyman, Lena Lilius, Charlotte Forsell, Caroline Graff.   

Abstract

Disease-associated gene polymorphisms provide both scientific insight into pathophysiological mechanisms and clinical information regarding risk and progression. Of special interest is the epsilon4 allele of the apolipoprotein E gene, which has emerged as a substantial risk factor for late-onset forms of Alzheimer disease and also influences the risk of cardiovascular disease. Genotyping of apolipoprotein E can be performed by several methods; presented here are a quality and cost-benefit analysis of four different protocols on a cohort of 42 clinical samples is included in the unit. Each method resulted in genotyping with a high sensitivity and specificity. The newer microtiter-plate-based high-throughput techniques, fluorescence polarization and SNaPshot analysis, were as reliable as the traditional techniques of restriction fragment length polymorphism analysis and reverse hybridization. The reverse hybridization method tends to be more cost- and time-effective when the number of analyses is limited, although economy of scale favors fluorescence polarization or SNaPshot analysis in larger studies. The latter approaches also provide the flexibility to investigate other polymorphic disease markers.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 18428347     DOI: 10.1002/0471142905.hg0914s38

Source DB:  PubMed          Journal:  Curr Protoc Hum Genet        ISSN: 1934-8258


  8 in total

1.  Rapid progression from mild cognitive impairment to Alzheimer's disease in subjects with elevated levels of tau in cerebrospinal fluid and the APOE epsilon4/epsilon4 genotype.

Authors:  Elin S Blom; Vilmantas Giedraitis; Henrik Zetterberg; Hiroaki Fukumoto; Kaj Blennow; Bradley T Hyman; Michael C Irizarry; Lars-Olof Wahlund; Lars Lannfelt; Martin Ingelsson
Journal:  Dement Geriatr Cogn Disord       Date:  2009-05-07       Impact factor: 2.959

Review 2.  Biomarkers of Alzheimer disease in plasma.

Authors:  Michael C Irizarry
Journal:  NeuroRx       Date:  2004-04

3.  Stable size distribution of amyloid plaques over the course of Alzheimer disease.

Authors:  Alberto Serrano-Pozo; Matthew L Mielke; Alona Muzitansky; Teresa Gómez-Isla; John H Growdon; Brian J Bacskai; Rebecca A Betensky; Matthew P Frosch; Bradley T Hyman
Journal:  J Neuropathol Exp Neurol       Date:  2012-08       Impact factor: 3.685

4.  Differential relationships of reactive astrocytes and microglia to fibrillar amyloid deposits in Alzheimer disease.

Authors:  Alberto Serrano-Pozo; Alona Muzikansky; Teresa Gómez-Isla; John H Growdon; Rebecca A Betensky; Matthew P Frosch; Bradley T Hyman
Journal:  J Neuropathol Exp Neurol       Date:  2013-06       Impact factor: 3.685

5.  Reactive glia not only associates with plaques but also parallels tangles in Alzheimer's disease.

Authors:  Alberto Serrano-Pozo; Matthew L Mielke; Teresa Gómez-Isla; Rebecca A Betensky; John H Growdon; Matthew P Frosch; Bradley T Hyman
Journal:  Am J Pathol       Date:  2011-07-21       Impact factor: 4.307

Review 6.  A brief review of molecular techniques to assess plant diversity.

Authors:  Ibrahim A Arif; Mohammad A Bakir; Haseeb A Khan; Ahmad H Al Farhan; Ali A Al Homaidan; Ali H Bahkali; Mohammad Al Sadoon; Mohammad Shobrak
Journal:  Int J Mol Sci       Date:  2010-05-10       Impact factor: 5.923

7.  Trajectories of inflammatory markers and cognitive decline over 10 years.

Authors:  Andrea L Metti; Kristine Yaffe; Robert M Boudreau; Eleanor M Simonsick; Ryan M Carnahan; Suzanne Satterfield; Tamara B Harris; Hilsa N Ayonayon; Caterina Rosano; Jane A Cauley
Journal:  Neurobiol Aging       Date:  2014-06-06       Impact factor: 4.673

8.  Challenges at the APOE locus: a robust quality control approach for accurate APOE genotyping.

Authors:  Michael E Belloy; Sarah J Eger; Yann Le Guen; Vincent Damotte; Shahzad Ahmad; M Arfan Ikram; Alfredo Ramirez; Anthoula C Tsolaki; Giacomina Rossi; Iris E Jansen; Itziar de Rojas; Kayenat Parveen; Kristel Sleegers; Martin Ingelsson; Mikko Hiltunen; Najaf Amin; Ole Andreassen; Pascual Sánchez-Juan; Patrick Kehoe; Philippe Amouyel; Rebecca Sims; Ruth Frikke-Schmidt; Wiesje M van der Flier; Jean-Charles Lambert; Zihuai He; Summer S Han; Valerio Napolioni; Michael D Greicius
Journal:  Alzheimers Res Ther       Date:  2022-02-04       Impact factor: 6.982

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.